BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Albazaz R, Patel CN, Chowdhury FU, Scarsbrook AF. Clinical impact of FDG PET-CT on management decisions for patients with primary biliary tumours. Insights Imaging. 2013;4:691-700. [PMID: 23884572 DOI: 10.1007/s13244-013-0268-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Sabaté-llobera A, Gràcia-sánchez L, Reynés-llompart G, Ramos E, Lladó L, Robles J, Serrano T, Mestres-martí J, Gámez-cenzano C. Differences on metabolic behavior between intra and extrahepatic cholangiocarcinomas at 18F-FDG–PET/CT: prognostic implication of metabolic parameters and tumor markers. Clin Transl Oncol 2019;21:324-33. [DOI: 10.1007/s12094-018-1926-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
2 Kang X, Li F, Gao H, Wang S. Imaging performance and preoperative differential diagnosis of multiple myopericytoma in the liver: A case report. Mol Clin Oncol 2020;13:66. [PMID: 33014365 DOI: 10.3892/mco.2020.2136] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Delgado Cordón F, Vizuete Del Río J, Martín-Benítez G, Ripollés González T, Martínez Pérez MJ. Bile duct tumors. Radiologia 2015;57:101-12. [PMID: 25554118 DOI: 10.1016/j.rx.2014.10.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Ho J, Curley SA. Diagnosis and Management of Intrahepatic and Extrahepatic Cholangiocarcinoma. Cancer Treat Res 2016;168:121-63. [PMID: 29206368 DOI: 10.1007/978-3-319-34244-3_7] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 Annunziata S, Pizzuto DA, Caldarella C, Galiandro F, Sadeghi R, Treglia G. Diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography in gallbladder cancer: A meta-analysis. World J Gastroenterol 2015; 21(40): 11481-11488 [PMID: 26523112 DOI: 10.3748/wjg.v21.i40.11481] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
6 Huang X, Yang J, Li J, Xiong Y. Comparison of magnetic resonance imaging and 18-fludeoxyglucose positron emission tomography/computed tomography in the diagnostic accuracy of staging in patients with cholangiocarcinoma: A meta-analysis. Medicine (Baltimore) 2020;99:e20932. [PMID: 32871859 DOI: 10.1097/MD.0000000000020932] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Baheti AD, Tirumani SH, Rosenthal MH, Shinagare AB, Ramaiya NH. Diagnosis and management of intrahepatic cholangiocarcinoma: a comprehensive update for the radiologist. Clin Radiol. 2014;69:e463-e470. [PMID: 25240565 DOI: 10.1016/j.crad.2014.08.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
8 Kinoshita M, Takemura S, Tanaka S, Shinkawa H, Hamano G, Ito T, Koda M, Aota T, Nakanuma Y, Sato Y, Nakamori S, Arimoto A, Yamamoto T, Toyokawa H, Kubo S. The Clinical Significance of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Patients with Occupational Cholangiocarcinoma. Asian Pac J Cancer Prev 2018;19:1753-9. [PMID: 30049183 DOI: 10.22034/APJCP.2018.19.7.1753] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Jiang L, Tan H, Panje CM, Yu H, Xiu Y, Shi H. Role of 18F-FDG PET/CT Imaging in Intrahepatic Cholangiocarcinoma. Clin Nucl Med. 2016;41:1-7. [PMID: 26402131 DOI: 10.1097/rlu.0000000000000998] [Cited by in Crossref: 35] [Cited by in F6Publishing: 12] [Article Influence: 5.8] [Reference Citation Analysis]
10 Hu J, Tang J, Lin C, Chu Y, Liu N. Preoperative staging of cholangiocarcinoma and biliary carcinoma using 18F-fluorodeoxyglucose positron emission tomography: a meta-analysis. J Investig Med 2018;66:52-61. [DOI: 10.1136/jim-2017-000472] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
11 Gao ZJ, Wang FS. Current diagnosis and treatment of primary intrahepatic cholangiocarcinoma. Shijie Huaren Xiaohua Zazhi 2015; 23(31): 4939-4945 [DOI: 10.11569/wcjd.v23.i31.4939] [Reference Citation Analysis]
12 Hokonohara K, Noda T, Hatano H, Takata A, Hirota M, Oshima K, Tanida T, Komori T, Morita S, Imamura H, Iwazawa T, Akagi K, Hayashi S, Inada M, Adachi S, Dono K. Tubular adenoma of the common bile duct with uptake in 18F-FDG PET: A case report. Mol Clin Oncol 2016;4:35-8. [PMID: 26870353 DOI: 10.3892/mco.2015.676] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
13 Parida GK, Panda RA, Agrawal K. Impact of fluorine-18-fluorodeoxyglucose PET/computed tomography in staging of patients with gallbladder cancer: a systematic review and meta-analysis. Nucl Med Commun 2021;42:846-54. [PMID: 33741859 DOI: 10.1097/MNM.0000000000001405] [Reference Citation Analysis]
14 Ramachandran A, Srivastava DN, Madhusudhan KS. Gallbladder cancer revisited: the evolving role of a radiologist. Br J Radiol 2021;94:20200726. [PMID: 33090880 DOI: 10.1259/bjr.20200726] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Ringe KI, Wacker F. Radiological diagnosis in cholangiocarcinoma: Application of computed tomography, magnetic resonance imaging, and positron emission tomography. Best Pract Res Clin Gastroenterol. 2015;29:253-265. [PMID: 25966426 DOI: 10.1016/j.bpg.2015.02.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
16 Elias Y, Mariano AT Jr, Lu Y. Detection of Primary Malignancy and Metastases with FDG PET/CT in Patients with Cholangiocarcinomas: Lesion-based Comparison with Contrast Enhanced CT. World J Nucl Med 2016;15:161-6. [PMID: 27651736 DOI: 10.4103/1450-1147.167605] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Rayar M, Sulpice L, Edeline J, Garin E, Levi Sandri GB, Meunier B, Boucher E, Boudjema K. Intra-arterial yttrium-90 radioembolization combined with systemic chemotherapy is a promising method for downstaging unresectable huge intrahepatic cholangiocarcinoma to surgical treatment. Ann Surg Oncol. 2015;22:3102-3108. [PMID: 25623598 DOI: 10.1245/s10434-014-4365-3] [Cited by in Crossref: 60] [Cited by in F6Publishing: 53] [Article Influence: 8.6] [Reference Citation Analysis]
18 Lee Y, Yoo IR, Boo SH, Kim H, Park HL, Hyun O J. The Role of F-18 FDG PET/CT in Intrahepatic Cholangiocarcinoma. Nucl Med Mol Imaging. 2017;51:69-78. [PMID: 28250860 DOI: 10.1007/s13139-016-0440-y] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
19 Annunziata S, Caldarella C, Pizzuto DA, Galiandro F, Sadeghi R, Giovanella L, Treglia G. Diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography in the evaluation of the primary tumor in patients with cholangiocarcinoma: a meta-analysis. Biomed Res Int 2014;2014:247693. [PMID: 24955351 DOI: 10.1155/2014/247693] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
20 Obmann VC, Grosse-Hokamp N, Alberts I, Fulton N, Rassouli N, Siegel C, Avril N, Herrmann KA. Diagnosis and staging of hepatobiliary malignancies: Potential incremental value of (18)F-FDG-PET/MRI compared to MRI of the liver. Nuklearmedizin 2021. [PMID: 34102690 DOI: 10.1055/a-1486-3671] [Reference Citation Analysis]
21 Kim NH, Lee SR, Kim YH, Kim HJ. Diagnostic Performance and Prognostic Relevance of FDG Positron Emission Tomography/Computed Tomography for Patients with Extrahepatic Cholangiocarcinoma. Korean J Radiol 2020;21:1355-66. [PMID: 32767862 DOI: 10.3348/kjr.2019.0891] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]